Assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality
2011

Assessing Surfactant Use in Preterm Infants to Measure NICU Quality

Sample size: 3633 publication Evidence: moderate

Author Information

Author(s): Heather C Kaplan, Scott A Lorch, Jennifer Pinto-Martin, Mary Putt, Jeffrey H Silber

Primary Institution: Cincinnati Children's Hospital Medical Center

Hypothesis

Is surfactant use in infants 30 to 34 weeks' gestation with RDS a valid measure of neonatal intensive care unit quality?

Conclusion

Surfactant use in infants with RDS shows significant variation across hospitals, indicating potential as a quality measure, but challenges in measurement and adjustment remain.

Supporting Evidence

  • 46% of infants in the study received surfactant.
  • Surfactant use varied significantly across hospitals.
  • Increased admissions of extremely low birth weight infants were linked to higher surfactant use.
  • The correlation between surfactant use and in-hospital mortality was 0.37.

Takeaway

This study looked at how often preterm babies get a treatment called surfactant to see if it shows how good the hospital is at taking care of them.

Methodology

Data was collected from 16 hospitals on infants with RDS, analyzing surfactant use and comparing it with mortality rates.

Potential Biases

Potential coding errors in RDS diagnosis and variations in care prior to transfer may introduce bias.

Limitations

Challenges included defining RDS using administrative data and adjusting for severity of illness.

Participant Demographics

Mean gestational age was 32.2 weeks; 57.8% were male and 70.8% were white.

Statistical Information

P-Value

0.051

Confidence Interval

95% CI 1.02-3.19

Statistical Significance

p = 0.051

Digital Object Identifier (DOI)

10.1186/1472-6963-11-22

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication